Instrumentation Metrics' Noninvasive Glucose Monitor Pivotal Study Planned
This article was originally published in The Gray Sheet
Executive Summary
Instrumentation Metrics will complete a clinical trial later in March for its IM200 noninvasive glucose monitor in anticipation of a 300 to 400-patient, multi-center pivotal study. The Chandler, Arizona firm plans to submit a premarket approval application for the device in late 2002 or early 2003.
You may also be interested in...
Financings In Brief
SonoSite: Handheld digital ultrasound device manufacturer plans secondary offering of 2.7 mil. shares of common stock. Assuming a public offering price of $22.95 per share, estimated net proceeds would be about $57.8 mil., according to a Feb. 22 prospectus filed with the Securities and Exchange Commission. The funds will be used for general corporate purposes, which may include expanded sales and marketing efforts for the SonoSite 180Plus and SonoHeart Elite ultrasound devices, as well as expanded manufacturing, R&D and potential acquisitions, SonoSite says. The Bothell, Washington firm has granted managing underwriters UBS Warburg and Deutsche Banc Alex. Brown the option to purchase an additional 405,000 shares to cover any over allotments, which could boost net proceeds to $66.5 mil., according to SonoSite...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.